Flair Jose Carrilho
Overview
Explore the profile of Flair Jose Carrilho including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
168
Citations
2075
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Trebicka J, Aguilar F, Farias A, Lozano J, Sanchez-Garrido C, Uson-Raposo E, et al.
Gut
. 2025 Feb;
PMID: 40011033
Background And Aims: Quantifying systemic inflammation (SI) in acutely decompensated cirrhosis (ADC) is of major importance because SI is a driver of the most severe forms of ADC, including acute-on-chronic...
2.
Rocha B, Ferreira L, Vianna L, Ciconelle A, Cortez Filho J, Nogueira L, et al.
Clinics (Sao Paulo)
. 2024 Oct;
79:100512.
PMID: 39388738
Background: Hepatocellular carcinoma (HCC) is a prevalent tumor with high mortality rates. Computed tomography (CT) is crucial in the non-invasive diagnosis of HCC. Recent advancements in artificial intelligence (AI) have...
3.
Pinho J, Gomes-Gouvea M, Carrilho F
Ann Hepatol
. 2024 Sep;
29(6):101575.
PMID: 39270981
No abstract available.
4.
da Fonseca L, Yamamoto V, Cunha M, Torre G, Araujo R, Fonseca G, et al.
J Hepatocell Carcinoma
. 2023 Nov;
10:1923-1933.
PMID: 37933267
Purpose: Fibrolamellar hepatocellular carcinoma (FLHCC) is a rare primary liver malignancy often diagnosed at advanced stages. While there are limited data on the efficacy of specific agents, we aim to...
5.
Nassar-Reis J, Umeta P, Stefano J, Longatto-Filho A, Carrilho F, Alves V, et al.
J Mol Histol
. 2023 Aug;
54(5):473-488.
PMID: 37605073
The efficacy of systemic therapy for hepatocellular carcinoma (HCC) related to non-alcoholic steatohepatitis (NASH) is poorly understood. In this study we evaluated the effects of sorafenib based on the expression...
6.
Chagas A, Leal C, Mello V, Barros F, Bittencourt P, Mattos A, et al.
Arq Gastroenterol
. 2023 May;
60(1):106-131.
PMID: 37194769
Hepatocellular carcinoma (HCC) is the third most common cause of cancer-related mortality worldwide. The Brazilian Society of Hepatology (SBH) published in 2020 the updated recommendations for the diagnosis and treatment...
7.
Paranagua-Vezozzo D, Terrabuio D, Reinoso-Pereira G, Moutinho R, Ono S, Walwyn Salas V, et al.
JGH Open
. 2023 May;
7(4):272-277.
PMID: 37125250
Background And Aim: The aim was to analyze the concordance of liver stiffness measurement (LSM) either by transient elastography (TE) or ARFI with liver biopsy in autoimmune hepatitis (AIH) patients...
8.
da Fonseca L, Uratani L, Soares G, Siqueira Do Amaral P, De Souza Melo Alencar R, Chagas A, et al.
Mol Clin Oncol
. 2023 Mar;
18(4):29.
PMID: 36908977
Prognostic markers in advanced hepatocellular carcinoma (HCC) are relevant for clinical decisions. Variations in inflammatory indexes, such as neutrophil-to-lymphocyte ratio (NLR) or platelet-to-lymphocyte ratio (PLR), may correlate with outcomes. In...
9.
Rocha B, Ferreira L, Vianna L, Gomes Ferreira L, Ciconelle A, Da Silva Noronha A, et al.
Sci Rep
. 2022 Nov;
12(1):20315.
PMID: 36434070
Hepatocellular carcinoma (HCC) has become the 4th leading cause of cancer-related deaths, with high social, economical and health implications. Imaging techniques such as multiphase computed tomography (CT) have been successfully...
10.
Recuero A, Gomes L, Maciel G, de Mello Malta F, Salles A, Vezozzo D, et al.
Biomedicines
. 2022 Nov;
10(11).
PMID: 36359239
Background: The aim of this study was to determine the frequency of the rs738409 polymorphism in the patatin-like phospholipase domain containing 3 (PNPLA3) gene in patients with polycystic ovary syndrome...